A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC) — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(63 sites)
United States
Research Site, Santa Monica, California Research Site, Santa Rosa, California Research Site, Atlanta, Georgia Research Site, Baltimore, Maryland Research Site, Houston, Texas Last updated February 2026